{ "items": [ "\n\n
\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n14 April 2020
\n \n \n \nResearch carried out by George Tofaris and his team has led to the development of a new way to test for Parkinson\u2019s disease before the main symptoms occur. This could allow clinicians to identify patients who would benefit from precision therapies that are currently at clinical trial stage.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Event\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n6 April 2020
\n \n \n \nDr Alexander Davies summarises a departmental seminar by Dr Simon Rinaldi
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n\n \n\n\n
\n \n\n \n11 February 2020
\n \n \n \nThe NIHR Research and Innovation for Global Health Transformation (RIGHT) programme has awarded \u00a34.9 million to help fund a project investigating epilepsy in sub-Saharan Africa.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n17 January 2020
\n \n \n \nDr Arjune Sen is leading a new six-month trial funded by the MRC Confidence in Concept scheme. The study is known as IliAD (Investigation of Levetiracetam in Alzheimer's Disease).
\n \n\n \n \n\n \n\n \n \n \n \n Award\n \n \n \n \n Clinical Neurology\n \n \n\n \n\n\n
\n \n\n \n18 December 2019
\n \n \n \nThe Oxford Parkinson's Disease Centre received the award for their contribution to the Critical Path for Parkinson\u2019s initiative
\n \n\n \n \n\n \n\n \n \n \n \n Award\n \n \n \n \n Clinical Neurology\n \n \n\n \n\n\n
\n \n\n \n17 December 2019
\n \n \n \nEmeritus Professor Angela Vincent received the Research Recognition Award, clinical science, at the annual meeting of the American Epilepsy Society.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n11 November 2019
\n \n \n \nNDCN\u2019s Associate Professor Andrea Nemeth is leading the Oxford part of a clinical trial for Hungtinton\u2019s disease.
\n \n\n \n \n\n \n\n \n \n \n \n Award\n \n \n \n \n Clinical Neurology\n \n \n\n \n\n\n
\n \n\n \n8 November 2019
\n \n \n \nThe Graham Bull Prize in Clinical Science / Goulstonian Lectureship is a prestigious annual prize awarded by the Royal College of Physicians
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n\n \n\n\n
\n \n\n \n20 October 2019
\n \n \n \nThe Oxford Epilepsy Research Group is at the forefront of some potentially ground-breaking work with patients who have drug-resistant epilepsy. Epilepsy affects over 50 million people worldwide and nearly one in three people with epilepsy are resistant to current drugs.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n14 October 2019
\n \n \n \nOur Neurometrology Group has published findings from its OxQUIP study looking at how eye movements are affected by medication in Parkinson's.
\n \n\n \n \n\n \n\n \n \n \n \n Award\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n1 August 2019
\n \n \n \nThis is one of six new Oxford-Celgene Fellowships, which give postdoctoral researchers exposure to the field of commercial drug discovery and development.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n31 July 2019
\n \n \n \nOur researchers have found that a simple test carried out on a smartphone can help to predict future change in people in the early stages of Parkinson\u2019s.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Teaching\n \n \n\n \n\n\n
\n \n\n \n25 July 2019
\n \n \n \nThe delivery of clinical care, research, and education in neuro-rehabilitation in Oxford will be revolutionised by an innovative partnership with Quinnipiac University, Hartford, USA.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n16 April 2019
\n \n \n \nLifeArc, one of the UK\u2019s leading medical research charities, has signed a deal to license an ion channel drug discovery programme to Daiichi Sankyo Company, Limited.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n4 April 2019
\n \n \n \nHow do we decide what to do in any given situation? We need to work out the payoffs and costs of actions \u2013 what we will gain and what it might cost us. But what is the exact nature of the mechanism in the brain which weighs up these payoffs and costs?
\n \n\n \n \n\n \n\n \n \n \n \n Award\n \n \n \n \n Clinical Neurology\n \n \n\n \n\n\n
\n \n\n \n28 March 2019
\n \n \n \nProfessor Tipu Aziz from the Nuffield Department of Surgical Sciences (NDS) has been awarded the Medal of the Society of British Neurological Surgeons (SBNS) for his lifetime achievement in neurosurgery.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Integrative Neuroimaging\n \n \n \n \n Public engagement\n \n \n\n \n\n\n
\n \n\n \n21 March 2019
\n \n \n \nBrain Awareness Week is an annual global initiative designed to raise awareness among the public about brain-related research and the impact that neuroscientists are having on the world.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n8 March 2019
\n \n \n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n21 February 2019
\n \n \n \nPaper published in Lancet Psychiatry may help with the accurate detection of this form of autoimmune encephalitis
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n12 February 2019
\n \n \n \nA new consortium of 27 partners coordinated by our department will tackle the challenge of discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative and metabolic diseases.
\n \n\n \n \n